Biofrontera Inc. (NASDAQ:BFRIW) Stock Short Interest Drops 99.7%

Biofrontera Inc. (NASDAQ:BFRIW) saw a large decline in short interest during the month of October. As of October 30th, there was short interest totaling 7 shares, a decline of 99.7% from the October 15th total of 2,190 shares. Based on an average trading volume of 12,811 shares, the short-interest ratio is currently 0.0 days.

Biofrontera Price Performance

BFRIW stock remained flat at $0.00 during midday trading on Thursday. The business has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.03. Biofrontera has a one year low of $0.00 and a one year high of $0.15.

Biofrontera Company Profile

Biofrontera Inc. is a biopharmaceutical company focused on dermatology. It develops and commercializes treatments for sun-damaged skin and other conditions, with an emphasis on photodynamic therapy, which uses a light-sensitive medicine activated by a light source. Biofrontera Inc. became a separately traded U.S. company after its separation from Germany-based Biofrontera AG. BFRIW represents warrants associated with Biofrontera Inc., rather than the company’s common stock.